Dr Magnus Nicolson
@drmnicolson.bsky.social
Chief Executive Officer @ Invizius | Biotech & Immunology | Science-to-Market Innovation | Advancing Complement Therapeutics
https://www.linkedin.com/in/magnus-nicolson/
https://www.linkedin.com/in/magnus-nicolson/
Cold tumours don’t have to stay cold - this drug wakes the immune system. Lingyin Li’s team is making waves with STF-1623, a drug that flips “cold” tumours into “hot” ones by blocking ENPP1 and letting the innate immune system respond naturally.
Novel ENPP1-Blocking Drug Heats Up Cold Solid Tumors
Researchers develop immunotherapy drug STF-1623, which safely prevents cancer cells from hiding from the immune system’s first responders
www.technologynetworks.com
September 15, 2025 at 10:37 AM
Cold tumours don’t have to stay cold - this drug wakes the immune system. Lingyin Li’s team is making waves with STF-1623, a drug that flips “cold” tumours into “hot” ones by blocking ENPP1 and letting the innate immune system respond naturally.